✦ LIBER ✦
Tolerability of 40 kDa peginterferon alfa-2A (PEGASYS®) versus standard interferon alfa-2B/ribavirin combination therapy (IFN/RBV) in patients with chronic hepatitis C (CHC): Robert P Perrillo, Ochsner Clinic, New Orleans, LA; Kenneth D Rothstein, Albert Einstein Medical Ctr, Philadelphia, PA; Paul J Thuluvath, Johns Hopkins Hospital, Baltimore, MD; Imtiaz Alam, Center for Clinical Research, Austin, TX; Joanne Imperial, Stanford Medical Center, Palo Alto, CA; Bradley Doerschuk, Lucy Wynohradnyk, S. Chris Pappas, Roche Laboratories Inc, Nutley, NJ
- Book ID
- 118688999
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 222 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.